Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
7.99
+0.03 (0.38%)
At close: Aug 29, 2025, 4:00 PM
7.99
0.00 (-0.06%)
After-hours: Aug 29, 2025, 4:38 PM EDT

Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.

It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc.
Inogen logo
CountryUnited States
Founded2001
IPO DateFeb 14, 2014
IndustryMedical Devices
SectorHealthcare
Employees766
CEOKevin R. Smith

Contact Details

Address:
859 Ward Drive
Goleta, California 93111
United States
Phone805 562 0500
Websiteinogen.com

Stock Details

Ticker SymbolINGN
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001294133
CUSIP Number45780L104
ISIN NumberUS45780L1044
SIC Code3842

Key Executives

NamePosition
Kevin R. M. SmithPresident, Chief Executive Officer and Director
Michael J. Bourque CPAExecutive Vice President, Chief Financial Officer and Corporate Treasurer
Kevin P. SmithGeneral Counsel, Secretary and Executive Vice President of Business Development
Grgoire RamadeExecutive Vice President and Chief Commercial Officer
Philip CorrinSenior Vice President of Operations and Supply Chain
Mary WrightChief Accounting Officer
Ryan PetersonAssociate Director of Investor Relations
Jennifer Yi BoyerExecutive Vice President of Enterprise Enablement and Chief Human Resources Officer
Dr. Krishna JhaveriChief Medical Officer
Paul AndreassiSenior Vice President of Quality and Regulatory Affairs

Latest SEC Filings

DateTypeTitle
Aug 8, 202510-QQuarterly Report
Aug 7, 20258-KCurrent Report
Jul 29, 20258-KCurrent Report
Jul 17, 2025SCHEDULE 13G/AFiling
May 29, 2025SDForm - SD
May 20, 2025S-8Securities to be offered to employees in employee benefit plans
May 19, 20258-KCurrent Report
May 15, 2025SCHEDULE 13G/AFiling
May 15, 2025SCHEDULE 13G/AFiling
May 8, 202510-QQuarterly Report